Indefinite Delivery Contract W81K0225DA021
Award Date 10/1/25
Last Date to Order 9/30/28
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Roche Diagnostics Corporation was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency with a ceiling value of $215,748.90, effective from October 1, 2025, through September 30, 2028. The contract, issued without set-aside designation, provides blood gas reagents, supplies, maintenance, and training services for Madigan Army Medical Center in Tacoma, Washington. This indefinite delivery vehicle serves as the parent contract mechanism enabling the government to issue...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory instruments, received a single-award Indefinite Delivery Contract from the Defense Health Agency (DHA) on October 1, 2023, with a ceiling value of $7.42 million and an ultimate completion date of June 30, 2028. The contract procures chemistry reagents to support laboratory diagnostic operations across military and defense healthcare systems. The IDV does not utilize small business set-asides,...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory reagents, was awarded a single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract by the Defense Health Agency on September 23, 2022, with a ceiling value of $6.5 million and an ultimate completion date of September 22, 2027. The contract covers Roche Diagnostics Laboratory Library Preparation Kits and related consumable laboratory test and quantification materials. The primary places of...
- The Defense Health Agency awarded a single-award Indefinite Delivery Contract to Roche Diagnostics Corporation on October 1, 2023, with a ceiling value of $10,938,777.37 and an ultimate completion date of September 30, 2028. This contract procures chemistry and immunoassay testing supplies and services under a cost-per-reportable-result pricing model. Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical...
- The Defense Health Agency has awarded a single-award Blanket Purchase Agreement to Roche Diagnostics Corporation (UEI: JDMDFEZBYH36) with a ceiling value of $606,000 for the provision of chemistry analyzer equipment and associated reagents on a cost-per-reportable-result basis. The contract, effective from October 1, 2025, through March 31, 2027, establishes a pricing mechanism that ties reimbursement directly to clinical testing output, enabling efficient procurement of diagnostic laboratory...
- The provided information details an Indefinite Delivery Contract (IDC) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and associated products and services. The 5-year, $9,160,241.71 IDC allows DHA to issue delivery orders for Roche's Total Laboratory Automation Systems and Cobas 8000 analyzers to support operations at Madigan Army Medical Center in Tacoma, Washington. Under the IDC,...
- Roche Diagnostics Corporation was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency on October 1, 2021, for the supply of histology test reagents and Roche Diagnostics Ventana Medical System platform reagents. The indefinite delivery vehicle maintains a ceiling value of $1,774,824.38 and extends through September 30, 2026, with no set-aside designation. The contract was awarded on an open competitive basis and represents a firm-fixed-price arrangement under which...
- The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Roche Diagnostics Corporation for the leasing of tissue staining equipment, services, and reagents with a ceiling value of $20,000,000 and a period of performance through May 4, 2030. This contract was awarded on May 1, 2025, without any set-aside designation, allowing Roche to compete openly in the federal marketplace. The contract vehicle enables the Defense Health Agency to efficiently procure diagnostic laboratory...
- The Defense Health Agency awarded a single-award Indefinite Delivery Contract to Roche Diagnostics Corporation for a fully automated sample preparation and consultation system supporting the Department of Pathology and Area Laboratory Services histology laboratory at Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. The contract, valued at $6.75 million with a period of performance from October 1, 2025, through September 30, 2029, was awarded without set-aside designation to this...
- Roche Diagnostics Corporation has been awarded an indefinite delivery contract by the Department of the Army Medical Command to provide immunochemistry testing services. The single award contract has a potential value of $16.6M and period of performance through September 2023. Under the contract vehicle, Roche has received multiple delivery orders to conduct clinical chemistry and immunoassay testing at its facility in Castleton, Indiana for various Army medical treatment facilities. Orders have...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order W81K0225DA021-W81K0225FA154 | Roche Diagnostics Corporation | $1.9m | 10/1/25 | 9/30/26 | 9/18/25 |